JP

Jyotsna Polepally

Active Director Director DIN 08027644
DIN 08027644 First appointment Apr 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Jyotsna Polepally

Data last updated:

Jyotsna Polepally is a Director at Unicept Pharma Private Limited (since 2018). The company operates in Pharma.

DIN 08027644
Primary Designation Director
Industry Pharma
First Appointment 18 Apr 2018
Oldest Company Age 13 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Unicept Pharma Private Limited U24232TG2013PTC089820
Director18 Apr 20182013Active

Board colleagues of Jyotsna Polepally

NameDINCompanyDesignation
Vinaya Kathagandla08028417Unicept Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Unicept Pharma Private Limited
Premium access

Shareholding and investment profile for Jyotsna Polepally

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyotsna Polepally

Jyotsna Polepally currently holds 1 directorship: Unicept Pharma Private Limited (Director, since 18 Apr 2018).

Jyotsna Polepally was first appointed on 18 Apr 2018 as Director at Unicept Pharma Private Limited.

The current boards of Jyotsna Polepally's companies include Vinaya Kathagandla (Unicept Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available